Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.
Santini D, Schiavon G, Vincenzi B, Gaeta L, Pantano F, Russo A, Ortega C, Porta C, Galluzzo S, Armento G, La Verde N, Caroti C, Treilleux I, Ruggiero A, Perrone G, Addeo R, Clezardin P, Muda AO, Tonini G. Santini D, et al. Among authors: clezardin p. PLoS One. 2011 Apr 29;6(4):e19234. doi: 10.1371/journal.pone.0019234. PLoS One. 2011. PMID: 21559440 Free PMC article.
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body JJ, Markopoulos C, Santini D, Diel I, Di Leo A, Cameron D, Dodwell D, Smith I, Gnant M, Gray R, Harbeck N, Thurlimann B, Untch M, Cortes J, Martin M, Albert US, Conte PF, Ejlertsen B, Bergh J, Kaufmann M, Holen I. Hadji P, et al. Among authors: clezardin p. Ann Oncol. 2016 Mar;27(3):379-90. doi: 10.1093/annonc/mdv617. Epub 2015 Dec 17. Ann Oncol. 2016. PMID: 26681681 Free article. Review.
RANK/RANKL pathway in cancer: Biological activity beyond bone?
Pantano F, Clézardin P, Santini D. Pantano F, et al. Among authors: clezardin p. J Bone Oncol. 2012 Nov 29;1(3):67-8. doi: 10.1016/j.jbo.2012.11.001. eCollection 2012 Dec. J Bone Oncol. 2012. PMID: 26909258 Free PMC article. No abstract available.
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone.
Fradet A, Bouchet M, Delliaux C, Gervais M, Kan C, Benetollo C, Pantano F, Vargas G, Bouazza L, Croset M, Bala Y, Leroy X, Rosol TJ, Rieusset J, Bellahcène A, Castronovo V, Aubin JE, Clézardin P, Duterque-Coquillaud M, Bonnelye E. Fradet A, et al. Among authors: clezardin p. Oncotarget. 2016 Nov 22;7(47):77071-77086. doi: 10.18632/oncotarget.12787. Oncotarget. 2016. PMID: 27776343 Free PMC article.
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
Croset M, Pantano F, Kan CWS, Bonnelye E, Descotes F, Alix-Panabières C, Lecellier CH, Bachelier R, Allioli N, Hong SS, Bartkowiak K, Pantel K, Clézardin P. Croset M, et al. Among authors: clezardin p. Cancer Res. 2018 Sep 15;78(18):5259-5273. doi: 10.1158/0008-5472.CAN-17-3058. Epub 2018 Jul 24. Cancer Res. 2018. PMID: 30042152 Free article.
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.
Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, Kan C, Benetollo C, Brevet M, Croset M, Mazel M, Cayrefourcq L, Geraci S, Vacher S, Pantano F, Filipits M, Driouch K, Bieche I, Gnant M, Jacot W, Aubin JE, Duterque-Coquillaud M, Alix-Panabières C, Clézardin P, Bonnelye E. Vargas G, et al. Among authors: clezardin p. Oncogene. 2019 Feb;38(7):950-964. doi: 10.1038/s41388-018-0579-3. Epub 2018 Nov 26. Oncogene. 2019. PMID: 30478447 Free article.
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.
Pantano F, Croset M, Driouch K, Bednarz-Knoll N, Iuliani M, Ribelli G, Bonnelye E, Wikman H, Geraci S, Bonin F, Simonetti S, Vincenzi B, Hong SS, Sousa S, Pantel K, Tonini G, Santini D, Clézardin P. Pantano F, et al. Among authors: clezardin p. Oncogene. 2021 Feb;40(7):1284-1299. doi: 10.1038/s41388-020-01603-6. Epub 2021 Jan 8. Oncogene. 2021. PMID: 33420367 Free PMC article.
MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.
Puppo M, Valluru MK, Croset M, Ceresa D, Iuliani M, Khan A, Wicinski J, Charafe-Jauffret E, Ginestier C, Pantano F, Ottewell PD, Clézardin P. Puppo M, et al. Among authors: clezardin p. Br J Cancer. 2023 Sep;129(5):754-771. doi: 10.1038/s41416-023-02340-9. Epub 2023 Jul 13. Br J Cancer. 2023. PMID: 37443350 Free PMC article.
174 results